Caterina Stelitano
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 94
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 48
- Neurology top 0.5%
- CNS Lymphoma Diagnosis and Treatment 33
- Oncology top 2%
- Viral-associated cancers and disorders 28
- Hematology top 5%
- Multiple Myeloma Research and Treatments 6
-
- Lung Cancer Treatments and Mutations 21
-
- Acute Lymphoblastic Leukemia research 9
-
- Medical Imaging Techniques and Applications 6
- Co-authors
- Francesco MerliStefano LuminariLuigi RigacciUmberto VitoloMassimo FedericoFortunato MorabitoLuca BaldiniVincenzo Callea
- Partner nations
- ItalyUkraineSwitzerland
In The Last Decade
Caterina Stelitano
112 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Pathology and Forensic Medicine 3.0k
- Genetics 1.1k
- Neurology 1.3k
- Oncology 1.4k
- Hematology 348
Countries citing papers authored by Caterina Stelitano
This map shows the geographic impact of Caterina Stelitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Stelitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Stelitano more than expected).
Fields of papers citing papers by Caterina Stelitano
This network shows the impact of papers produced by Caterina Stelitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Stelitano. The network helps show where Caterina Stelitano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Caterina Stelitano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 23 | |
| 2 | 2015 | 4 | |
| 3 | 2014 | 106 | |
| 4 | 2012 | 117 | |
| 5 | 2012 | 7 | |
| 6 | 2009 | 6 | |
| 7 | 2008 | 65 | |
| 8 | Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Studybreakdown → | 2007 | 552 |
| 9 | 2007 | 33 | |
| 10 | 2006 | 18 | |
| 11 | 2005 | 41 | |
| 12 | 2005 | 20 | |
| 13 | 2005 | 104 | |
| 14 | 2005 | 9 | |
| 15 | 2004 | 58 | |
| 16 | 2004 | 38 | |
| 17 | 2004 | 4 | |
| 18 | 2003 | 20 | |
| 19 | 2001 | 44 | |
| 20 | 1999 | 10 |
About Caterina Stelitano
Caterina Stelitano is a scholar working on Genetics, Pathology and Forensic Medicine and Neurology, having authored 114 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (94 papers), Chronic Lymphocytic Leukemia Research (48 papers), CNS Lymphoma Diagnosis and Treatment (33 papers), Viral-associated cancers and disorders (28 papers), Lung Cancer Treatments and Mutations (21 papers), Acute Lymphoblastic Leukemia research (9 papers), Medical Imaging Techniques and Applications (6 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.0k citations), Genetics (1.1k citations) and Neurology (1.3k citations). Caterina Stelitano has collaborated with scholars based in Italy, Ukraine and Switzerland. Frequent co-authors include Francesco Merli, Stefano Luminari, Luigi Rigacci, Umberto Vitolo, Massimo Federico, Fortunato Morabito, Luca Baldini, Vincenzo Callea, Maura Brugiatelli and Emilio Iannitto. Their work appears in journals such as Journal of Clinical Oncology, Blood and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.